• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for mike schuster

mike schuster

Beating The Odds

Brain cancer survivor Mike Schuster celebrates a milestone he never thought possible.

Oblato acquires all rights to glioblastoma drug from OMRF

October 29, 2018

Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.

Filed Under: News, Technology Ventures News Tagged With: 007, americans, brain, cancer, clinical, deadly, diagnosis, drug, edward kennedy, Gtree, james battiste, john mccain, Manu Nair, mike schuster, model, news, Norman, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OMRF, Rheal, rheal towner, robert floyd, scientist-news, Stephenson Cancer Center, technology, testing, therapy, Towner, treatment, trial, tumor, university of oklahoma

Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?

September 11, 2018

As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.

Filed Under: News, Technology Ventures News Tagged With: aggressive, battiste, brain, brain cancer, cancer, deadly, death, develop, disease, drug, glioblastoma, john mccain, life expectancy, live, longer, mike schuster, MRI, newsok, Norman, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OKN-007, OMRF, OUHSC, patients, Rheal, scientist-news, Stephenson Cancer Center, Towner, tumor

Staying Alive: Can an experimental OMRF drug stop Mike’s brain cancer?

Doctors exhausted conventional treatments for Mike Schuster. Can an experimental OMRF drug stop his brain cancer? *** In the summer of 2010, Mike and Teresa Schuster took their two boys to Mexico’s Yucatan Peninsula. The Schusters live in Norman, where Teresa is an administrative assistant in the University of Oklahoma’s Office of Student Affairs and […]

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace